Factors that Influence the Incidence of Depression in Breast Cancer Patients

Priharyanti Wulandari; P. H. Livana

doi:10.3889/oamjms.2022.7740

Authors

Priharyanti Wulandari Department of Nursing, Universitas Widya Husada, Semarang, Indonesia
P. H. Livana Department of Nursing, Sekolah Tinggi Ilmu Kesehatan Kendal, Sijeruk, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.7740

Keywords:

Incidence of depression, Breast cancer, Family support

Abstract

The prevalence of psychological distress in breast cancer patients is high, and they are at higher risk of experiencing severe anxiety, depression, and potential mood disorders. Depression that occurs in breast cancer patients is influenced by several factors. This study aims to determine the factors that influence the incidence of depression in breast cancer patients. The population of this study were all breast cancer patients in the outpatient clinic for oncology surgery and inpatient building A Zone A 2

^nd

floor at Dr. Cipto Mangunkusumo General Hospital Jakarta, the sample in this study was 102 respondents. The research design used in this study was cross-sectional. The measuring instrument used to measure the incidence of depression is to use depression screening tools in accordance with those used at Dr. Cipto Mangunkusumo General Hospital Jakarta. Items assessing socio-demography, physical symptom burden, social support, and medical and medication history, with complementary medical record reviews, were used to assess variables potentially associated with depressive symptoms. Logistic regression was used to identify associated factors. The incidence of depression in breast cancer patients was dominated by the group of respondents who did not experience depression as many as 57 people (55.9%), compared to the group of respondents who experienced depression as many as 45 people (44.1%). The results of the logistic regression showed that there was only family support variable which had a p = 0.002 < 0.005, meaning that family support was the most influential variable on the incidence of depression in breast cancer patients. It is recommended to reduce the incidence of depression, namely nurses should facilitate adequate family support for breast cancer patients to reduce the incidence of depression.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Prevelance of Breast Cancer. World Health Organization; 2021. Available from: http://medicastore. co.id/pdf [Last accessed on 2021 Aug 20].

Kemenkes RI KR. Pedoman Gizi Seimbang. Kemenkes RI KR; 2019.

Zainal NZ, Nik-Jaafar NR, Baharudin A, Sabki ZA, Ng CG. Prevalence of depression in breast cancer survivors: A systematic review of observational studies. Asian Pac J Cancer Prev. 2013;14(4):2649-56. https://doi.org/10.7314/apjcp.2013.14.4.2649 PMid:23725190 DOI: https://doi.org/10.7314/APJCP.2013.14.4.2649

Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review. Maturitas. 2015;82(1):100-8. https://doi.org/10.1016/j.maturitas.2015.04.010 PMid:25998574 DOI: https://doi.org/10.1016/j.maturitas.2015.04.010

Batty G, Russ T, Stamatakis E, Kivimäki M. Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ. 2017;356:108. DOI: https://doi.org/10.1136/bmj.j108

Konstantinos T, Ioanna V, Mitsi D, Veneti A, Kelesi M, Zyga S, et al. Assessment of depression and anxiety in breast cancer patients: Prevalence and associated factors. Asian Pac J Cancer Prev. 2018;19(6):1661-9. https://doi.org/10.22034/APJCP.2018.19.6.1661

Christensen H, Marck D. The efficacy of mindfulness based stress reduction (MBSR) for decreasing anxiety and depression among breast cancer survivors. Sch Physician Assist Stud. 2017;16:613.

Engelhard J, Bleicher L, Kostev K. Prevalence of depression and anxiety and their risk factors in women with breast cancer in German primary care. Value Health. 2015;18:A431. DOI: https://doi.org/10.1016/j.jval.2015.09.1025

Srivastava V, Ansari MA, Kumar A, Shah AG, Meena RK, Sevach P, et al. Study of anxiety and depression among breast cancer patients from North India. Clin Psychiatry. 2016;2(1):1-7. DOI: https://doi.org/10.21767/2471-9854.100017

Hassan MR, Shah SA, Ghazi HF, Mujar NM, Samsuri MF, et al. Anxiety and depression among breast cancer patients in an urban setting in Malaysia. Asian Pac J Cancer Prev. 2015;16:4031-5. https://doi.org/10.7314/apjcp.2015.16.9.4031 PMid:25987081 DOI: https://doi.org/10.7314/APJCP.2015.16.9.4031

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: Results from the UK standardisation of radiotherapy trials (START). Breast. 2010;19(2):84-91. https://doi.org/10.1016/j.breast.2009.11.007 PMid:20042336 DOI: https://doi.org/10.1016/j.breast.2009.11.007

Bener A, Alsulaiman R, Doodson L, Agathangelou T. Depression, hopelessness and social support among breast cancer patients: in highly endogamous population. Asian Pac J Cancer Prev. 2017;18(7):1889-96. https://doi.org/10.22034/APJCP.2017.18.7.1889 PMid:28749617

Inhestern L, Beierlein V, Bultmann JC, Möller B, Romer G, Koch U, et al. Anxiety and depression in working-age cancer survivors: a register-based study. BMC Cancer. 2017;17:347. https://doi.org/10.1186/s12885-017-3347-9 PMid:28526007 DOI: https://doi.org/10.1186/s12885-017-3347-9

Rogers LQ, Courneya KS, Anton PM, Verhulst S, Vicari SK, Robbs RS, et al. Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: Randomized trial. Psychooncology. 2017;26(11):1901-6. https://doi.org/10.1002/pon.4254 PMid:27530961 DOI: https://doi.org/10.1002/pon.4254

Faller H, Strahl A, Richard M, Niehues C, Meng K. Symptoms of depression and anxiety as predictors of physical functioning in breast cancer patients. A prospective study using path analysis. Acta Oncol. 2017;56:1677-81. https://doi.org/10.1080/0284186X.2017.1333630 PMid:28595474 DOI: https://doi.org/10.1080/0284186X.2017.1333630

Tae YS, Heitkemper M, Kim MY. A path analysis: A model of depression in Korean women with breast cancer-mediating effects of self-esteem and hope. Oncol Nurs Forum. 2012;39(1):E49-57. https://doi.org/10.1188/12.ONF.E49-E57 PMid:22201668 DOI: https://doi.org/10.1188/12.ONF.E49-E57

Wani SQ, Khan T, Wani SY, Teli MA, Khan NA, Mir LR, et al. Breast specific functional and symptom analysis in female breast cancer survivors. J Cancer Res Ther. 2018;14(3):521-526. https://doi.org/10.4103/0973-1482.165867 PMid:29893309 DOI: https://doi.org/10.4103/0973-1482.165867

Burton CL, Galatzer-Levy IR, Bonanno GA. Treatment type and demographic characteristics as predictors for cancer adjustment: Prospective trajectories of depressive symptoms in a population sample. Health Psychol. 2015;34:602-9. https://doi.org/10.1037/hea0000145 PMid:25110839 DOI: https://doi.org/10.1037/hea0000145

Jafari A, Goudarzian AH, Nesami MB. Depression in wom en with breast cancer: A systematic review of cross-sectional studies in Iran. Asian Pac J Cancer Prev. 2018;19(1):1-7. https://doi.org/10.22034/APJCP.2018.19.1.1 PMid:29373872

Hudson D, Gehlert S. Considering the role of social determinants of health in Black-White breast cancer disparities. In: Bangs R, Davis LE, editors. Race and Social Problems: Restructuring Inequality. New York: Springer Press; 2015. p. 227-46. DOI: https://doi.org/10.1007/978-1-4939-0863-9_15